BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35152975)

  • 1. Metabolomics of peripheral artery disease.
    Ismaeel A; Lavado R; Koutakis P
    Adv Clin Chem; 2022; 106():67-89. PubMed ID: 35152975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary risk assessment and cardiovascular outcomes in peripheral arterial disease.
    Das JR; Eberhardt RT
    Cardiovasc Hematol Disord Drug Targets; 2013 Dec; 13(3):185-96. PubMed ID: 24479718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Peripheral Arterial Disease.
    Camargo-Arias E; Aponte-Rodriguez J; Banchs-Pieretti H; Altieri-Nieto PI
    Bol Asoc Med P R; 2015; 107(3):95-7. PubMed ID: 26742205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vascular diagnostics in peripheral arteries].
    Espinola-Klein C; Weißer G
    Internist (Berl); 2017 Aug; 58(8):787-795. PubMed ID: 28612128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.
    Lau JF; Weinberg MD; Olin JW
    Nat Rev Cardiol; 2011 May; 8(7):405-18. PubMed ID: 21629211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the pathophysiology and potential biomarkers for peripheral artery disease.
    Krishna SM; Moxon JV; Golledge J
    Int J Mol Sci; 2015 May; 16(5):11294-322. PubMed ID: 25993296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral arterial disease - screening in general practice.
    Haigh K; Bingley J; Golledge J; Walker PJ
    Aust Fam Physician; 2013 Jun; 42(6):391-5. PubMed ID: 23781546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic peripheral artery disease and antiplatelet management.
    Raparelli V; Proietti M; Napoleone L; Bucci T; Talerico G; Pignataro FS; Basili S
    Vasa; 2014 Sep; 43(5):309-25. PubMed ID: 25147008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
    ; Conte MS; Pomposelli FB; Clair DG; Geraghty PJ; McKinsey JF; Mills JL; Moneta GL; Murad MH; Powell RJ; Reed AB; Schanzer A; Sidawy AN;
    J Vasc Surg; 2015 Mar; 61(3 Suppl):2S-41S. PubMed ID: 25638515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of disease distribution of lower extremity peripheral arterial disease.
    Chen Q; Shi Y; Wang Y; Li X
    Angiology; 2015 Mar; 66(3):211-8. PubMed ID: 24650949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral artery disease: treatment overview].
    Ono T; Nakamura M
    Nihon Rinsho; 2014 Jul; 72(7):1294-7. PubMed ID: 25163324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease.
    Hernández-Aguilera A; Fernández-Arroyo S; Cabre N; Luciano-Mateo F; Baiges-Gaya G; Fibla M; Martín-Paredero V; Menendez JA; Camps J; Joven J
    Mediators Inflamm; 2018; 2018():2760272. PubMed ID: 30327580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.
    Bechelli C; Macabrey D; Deglise S; Allagnat F
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic Plaques of Lower Peripheral Arteries and Their Association with Cardiovascular Disease: An Autopsy Study.
    Nakamura E; Sato Y; Iwakiri T; Yamashita A; Moriguchi-Goto S; Maekawa K; Gi T; Asada Y
    J Atheroscler Thromb; 2017 Sep; 24(9):921-927. PubMed ID: 28367862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of lifestyle and risk factor modification on occlusive peripheral arterial disease outcomes: standard healthcare vs structured programme-for a randomised controlled trial protocol.
    Elfghi M; Jordan F; Dunne D; Gibson I; Jones J; Flaherty G; Sultan S; Tawfick W
    Trials; 2021 Feb; 22(1):138. PubMed ID: 33581715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease.
    Djahanpour N; Ahsan N; Li B; Khan H; Connelly K; Leong-Poi H; Qadura M
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002322
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered Metabolomic Profile in Patients with Peripheral Artery Disease.
    Ismaeel A; Franco ME; Lavado R; Papoutsi E; Casale GP; Fuglestad M; Mietus CJ; Haynatzki GR; Smith RS; Bohannon WT; Sawicki I; Pipinos II; Koutakis P
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31540015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms.
    Ring A; Ismaeel A; Wechsler M; Fletcher E; Papoutsi E; Miserlis D; Koutakis P
    Ther Adv Cardiovasc Dis; 2022; 16():17539447221096940. PubMed ID: 35583375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.